Frequently Asked Questions

Aurora TIC is a Testing, Inspection & Certification (TIC) industry consolidation venture. We acquire and partner with independent testing laboratories to build a unified North American TIC platform. We are not a testing laboratory ourselves — we are the consolidation vehicle that brings independent labs together.

Our acquisition process typically takes 60–90 days from initial contact to closing. Step 1: Discovery call to assess fit. Step 2: Non-disclosure agreement and preliminary financial review. Step 3: Letter of Intent (LOI) with indicative valuation. Step 4: Due diligence (financial, operational, accreditation). Step 5: Definitive purchase agreement and closing. We prioritize operational continuity — lab staff, clients, and culture are preserved post-acquisition.

We target independent testing laboratories with: $1M–$10M in annual revenue, ISO 17025 accreditation (preferred but not required), established client relationships in supplements, cosmetics, food, or environmental testing, North American operations (US & Canada), and a motivated seller — typically a founder approaching retirement or seeking liquidity.

We value labs primarily on EBITDA multiples, typically 3–5x trailing twelve-month EBITDA. Factors that increase valuation: ISO 17025 accreditation, recurring revenue from long-term clients, proprietary testing methods, specialized equipment, and strong management teams willing to stay post-acquisition. We also consider revenue growth trajectory and market position.

Aurora TIC offers investment opportunities through Simple Agreements for Future Equity (SAFE) and Convertible Preferred Shares (CCPS) for accredited investors. We are a FasterCapital partner. Our investment thesis is grounded in the $50B+ global TIC market, the proven consolidation playbook of Eurofins and Bureau Veritas, and our founding team's 25+ years of TIC operational experience. Contact us for our investor deck and data room access.

Our Partner Labs program allows independent testing laboratories to join the Aurora TIC network without a full acquisition. Partner labs gain access to our cross-referral network, shared marketing resources, and accreditation consulting — in exchange for a revenue-sharing arrangement on referred business. This is ideal for labs that want the benefits of network membership while maintaining full ownership.

No. Aurora TIC is a consolidation vehicle — we acquire and partner with existing independent labs. We do not operate testing laboratories directly. Our sister company Qalitex Laboratories is an ISO/IEC 17025 accredited testing facility that serves as a model for our acquisition targets.

The global TIC market exceeds $50 billion but remains highly fragmented. Companies like Eurofins Scientific grew from €1B to €6.7B in revenue through systematic acquisition of independent labs — creating economies of scale, shared infrastructure, and cross-referral networks. Aurora TIC is executing this same playbook in the underserved North American mid-market, targeting labs with $1M–$10M in revenue that are too small for institutional acquirers but too valuable to ignore.